AngioDynamics

AngioDynamics Shares Outstanding

The The number of shares of AngioDynamics (ANGO) as of Nov 4, 2026 is 41.22 M. In the previous year, The number of shares was 41.22 M — a change of 0.00% (lower).

Shares Outstanding

41.22 M

YoY

0.00%

Last updated:

In 2026, AngioDynamics had 41.22 M outstanding stocks, a 0.00% change from the 41.22 M stocks in the previous year.

The AngioDynamics Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2024
41.22 M USD
Jan 1, 2025
41.22 M USD
Jan 1, 2026
41.22 M USD
Jan 1, 2027 (e)
42.02 USD
Jan 1, 2028 (e)
42.02 USD
Jan 1, 2029 (e)
42.02 USD
Jan 1, 2030 (e)
42.02 USD
Jan 1, 2031 (e)
42.02 USD
The AngioDynamics Shares Outstanding history
YEARShares OutstandingYoY
est42.020.00%
est42.020.00%
est42.020.00%
est42.020.00%
est42.02-100.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M0.00%
41.22 M+117.33 M%
35.13-0.51%
35.31+39.35%
25.34+0.98%
25.09+1.48%
24.73+0.68%
24.56+3.00%
23.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AngioDynamics Number of shares

AngioDynamics shares outstanding

The number of shares of AngioDynamics was 41.4 M in 2025. This indicates how many shares AngioDynamics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2024
40.92 M Stocks
Jan 1, 2025
41.40 M Stocks
Jan 1, 2026
42.02 M Stocks
Jan 1, 2027 (e)
42.02 M Stocks
Jan 1, 2028 (e)
42.02 M Stocks
Jan 1, 2029 (e)
42.02 M Stocks
Jan 1, 2030 (e)
42.02 M Stocks
Jan 1, 2031 (e)
42.02 M Stocks

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating AngioDynamics's Shares Outstanding

AngioDynamics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in AngioDynamics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding AngioDynamics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in AngioDynamics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about AngioDynamics stock

The number of shares of AngioDynamics is 41.22 M in 2026.

The number of shares of AngioDynamics changed from 41.22 M to 41.22 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — AngioDynamics

All Key Metrics — AngioDynamics